1. Home
  2. Food
  3. News & Events from HFP
  4. Workshops, Meetings & Webinars on Food and Dietary Supplements
  5. Public Meeting on Listeria monocytogenes Prevention - 08/18/2026
  1. Workshops, Meetings & Webinars on Food and Dietary Supplements

Meeting | Mixed

Event Title
Public Meeting on Listeria monocytogenes Prevention
August 18 - 19, 2026

Date:
August 18 - 19, 2026
Day1:
Tue, Aug 18
Day2:
Wed, Aug 19

On This Page

Date:

August 18-19, 2026

Location:

The public meeting was held in person and virtually. The in-person meeting was held at:

U.S. Food and Drug Administration
Harvey W. Wiley Federal Building
5001 Campus Drive (auditorium)
College Park, MD 20740

The FDA hosted a public meeting on August 18-19, 2026, on Listeria monocytogenes prevention. This meeting was the first in a series of public engagements, including workshops and webinars, to discuss best practices for managing risks posed by Listeria monocytogenes (L. monocytogenes). These discussions highlighted the perspectives of individual stakeholders and complemented the agency's efforts to integrate the latest scientific advancements and emerging developments in the prevention of L. monocytogenes. During this event, there were presentations and listening sessions on the following topics:

  • Advances in the Understanding and Control of L. monocytogenes
  • Best Practices in L. monocytogenes prevention
  • L. monocytogenes Dose-Response Modeling: Applications and Advancements
  • Using Food Safety Management Systems for Controlling L. monocytogenes in Retail Environments
  • Preventing Listeriosis in an Era of Changing Demographics and Dietary Patterns

This public meeting included participation from domestic and foreign government agencies, food and equipment manufacturers and trade groups, consumer groups, standard-setting bodies, physicians, and academic researchers as well as staff at FDA. Participation from a diverse group of experts and stakeholders fostered robust discussion on Listeria prevention strategies.

Background

Listeria monocytogenes is the fourth-leading cause of death from foodborne illness in the United States (approximately 1250 cases and 170 deaths annually), posing the greatest risk to vulnerable populations including pregnant women, newborns and infants, adults over the age of 65, and immunocompromised persons. Outbreaks of listeriosis (the disease caused by L. monocytogenes) have been attributed to queso fresco-type cheeses, unpasteurized dairy products, and a variety of ready-to-eat products such as deli meats and raw or processed fruits and vegetables. Despite continued efforts, incidence rates of listeriosis have remained essentially static for more than a decade, indicating the need for new, collaborative approaches to reduce public health burden.

Event Materials

 Recordings

Submit Comments

Please submit comments related to these key questions. 

Submit comments electronically on https://www.regulations.gov to docket number FDA-2026-N-7914, Public Meeting on Listeria monocytogenes Prevention by November 2, 2026.

Submit written/paper submissions to Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Be sure to include docket number FDA-2026-N-7914 on each page of your written comments.  

Back to Top